Middle Eastern Dividend Stocks To Consider

The Middle Eastern stock markets have recently experienced a rebound, particularly in the UAE, where energy and financial shares have driven a recovery after several days of declines. As investors navigate these dynamic conditions, dividend stocks can offer stability and income potential amidst market fluctuations.

Advertisement

Top 10 Dividend Stocks In The Middle East

NameDividend YieldDividend Rating
Turkiye Garanti Bankasi (IBSE:GARAN)3.14%★★★★★☆
Saudi Telecom (SASE:7010)9.69%★★★★★☆
Saudi Awwal Bank (SASE:1060)6.25%★★★★★☆
Riyad Bank (SASE:1010)6.47%★★★★★☆
National General Insurance (P.J.S.C.) (DFM:NGI)7.05%★★★★★☆
National Bank of Ras Al-Khaimah (P.S.C.) (ADX:RAKBANK)6.37%★★★★★☆
Emaar Properties PJSC (DFM:EMAAR)7.52%★★★★★☆
Delek Group (TASE:DLEKG)6.63%★★★★★☆
Arab National Bank (SASE:1080)5.38%★★★★★☆
Anadolu Hayat Emeklilik Anonim Sirketi (IBSE:ANHYT)6.42%★★★★★☆

Click here to see the full list of 68 stocks from our Top Middle Eastern Dividend Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Delek Group (TASE:DLEKG)

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Delek Group Ltd. is an energy company involved in the exploration, development, production, and marketing of oil and gas both in Israel and internationally, with a market cap of ₪14.20 billion.

Operations: Delek Group Ltd. generates revenue from its operations in the development and production of oil and gas assets in the North Sea (₪9.45 billion) and oil and gas exploration and production in Israel and its surroundings (₪3.36 billion).

Dividend Yield: 6.6%

Delek Group's dividend payments are well-covered by earnings and cash flows, with a payout ratio of 54.2% and a cash payout ratio of 26.1%, respectively. Despite offering a competitive dividend yield in the IL market, its dividends have been volatile over the past decade, raising concerns about reliability. Recent financials show increased sales but decreased net income for Q2 2025 compared to last year, highlighting potential challenges amidst its high debt levels.

TASE:DLEKG Dividend History as at Sep 2025
TASE:DLEKG Dividend History as at Sep 2025

I.D.I. Insurance (TASE:IDIN)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: I.D.I. Insurance Company Ltd. offers a range of insurance products and services to both individual and corporate clients in Israel, with a market cap of ₪2.99 billion.

Operations: I.D.I. Insurance Company Ltd.'s revenue segments include a variety of insurance products and services tailored for both personal and business clients in Israel.

Dividend Yield: 6.5%

I.D.I. Insurance offers a competitive dividend yield of 6.48%, ranking in the top 25% within the IL market, though it is not well covered by free cash flows due to a high cash payout ratio of 264.1%. Despite a low payout ratio of 35.3% reflecting coverage by earnings, dividends have been volatile over the past decade. Recent financials show strong growth with Q2 net income rising to ILS 94.62 million from ILS 59.53 million year-on-year, indicating improved profitability amidst dividend stability concerns.

TASE:IDIN Dividend History as at Sep 2025
TASE:IDIN Dividend History as at Sep 2025

Mizrahi Tefahot Bank (TASE:MZTF)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Mizrahi Tefahot Bank Ltd. offers international, commercial, domestic, and personal banking services to individuals and businesses in Israel and abroad, with a market cap of ₪55.11 billion.

Operations: Mizrahi Tefahot Bank Ltd., along with its subsidiaries, generates revenue through a variety of banking services including international, commercial, domestic, and personal banking for both individuals and businesses.

Dividend Yield: 4%

Mizrahi Tefahot Bank's dividends have been volatile over the past decade, though they have shown growth during this period. The payout ratio is low at 42.6%, indicating dividends are well covered by earnings and expected to remain so in three years. However, the dividend yield of 3.98% is below the top quartile in the IL market. Recent financials reveal stable net income with ILS 1,453 million reported for Q2 2025, consistent with last year’s performance.

TASE:MZTF Dividend History as at Sep 2025
TASE:MZTF Dividend History as at Sep 2025

Taking Advantage

  • Unlock our comprehensive list of 68 Top Middle Eastern Dividend Stocks by clicking here.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About TASE:IDIN

I.D.I. Insurance

Provides insurance products and services to individuals and corporate customers in Israel.

Proven track record with adequate balance sheet and pays a dividend.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2554.7% undervalued
110 users have followed this narrative
0 users have commented on this narrative
24 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4859.0% undervalued
213 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43047.7% undervalued
20 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9953.6% undervalued
26 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
3132 logo
AstrisCorporateAdvisory on Macnica Holdings ·

Core business remains firm, new growth initiative delayed

Fair Value:JP¥2.61k19.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DI
divine_4y1uv
AIIO logo
divine_4y1uv on Robo.ai ·

Robo.ai Appoints Former INTERPOL President H.E. Dr. Ahmed Naser Al-Raisi as Chairman of Its Subsidiary Alif Holding

Fair Value:US$0.0027108.0k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BE
PRCT logo
Betsareoff on PROCEPT BioRobotics ·

PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin

Fair Value:US$25.2629.2% undervalued
4 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28032.1% undervalued
211 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.0% undervalued
97 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.2% undervalued
74 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0